Scott, Carper Draft Bill Extending At-Home Care Waivers For Patients

A bipartisan Senate duo, rallied by home-based care advocates, plans to push for a two-year extension of a pandemic waiver that allows in-home care to substitute for certain Medicare inpatient procedures, and they hope to get the measure tucked into the upcoming omnibus funding package, lobbyists say. The two-year extension would give lawmakers time to build support for permanent legislation making home-based use of telehealth and innovative technologies an alternative to certain inpatient procedures. The soon-to-be-introduced Hospital Inpatient Services Modernization...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 

FDA Aims To Expand Role Of Digital Health Tech As Part Of PDUFA

FDA hopes to lay the groundwork to expand the role of digital health technologies in drug development and reviews and increase reliance on decentralized trials as part of the seventh iteration of the prescription drug user fee agreements. House lawmakers have expressed support for the agency’s plans, while also touting legislation they think could help boost the efforts. Digital health technologies can help with conducting decentralized trials in which some or all trial-related procedures and data collection take place at...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 

Telehealth Platform Offers More Connectivity Through Zoom Integration

The telehealth company Current Health will begin integrating the popular videoconferencing system Zoom into its platform , allowing greater access for patients with bandwidth issues and the opportunity for multiple people to participate in appointments on separate devices. Paul Magnaghi, a leader of Zoom’s partner program, said the company hopes to work with more health systems on product integration in the future. “Current Health’s integration with Zoom improves the patient experience and reduces barriers to access by providing more reliable...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 




CMS Retools Direct Contracting, Announces ACO REACH Demo

Following months of heated debate on the future of the direct contracting demonstration, CMS on Thursday (Feb. 24) announced it is redesigning the model as a new ACO REACH initiative that will focus more on health equity and be better overseen by the agency than its predecessor. Senior CMS officials also said the controversy reaffirms the innovation center’s commitment to be transparent about its work and the center will keep lawmakers tuned in. The National Association of ACOs praised CMS’...
Overline: 
With a focus on equity and more monitoring,
Article Type: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 03/03/2022
CMS Volume: 
Vol. 25, No. 9
Author: 

Providers Notch Win As Judge Axes Key Pieces Of Surprise Billing Rule

Providers notched the first win in the battle over the most controversial piece of the surprise billing rule, with a federal judge agreeing with the Texas Medical Association’s (TMA) charge the Biden administration violated the statute when it directed arbiters to look at the medium in-network rate when resolving disputes. In a ruling late Wednesday, District Judge Jeremy Kernodle also agreed with plaintiffs that the administration failed to give stakeholders an opportunity to comment before the interim rule came out...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 03/03/2022
CMS Volume: 
Vol. 25, No. 9
HEA Issue: 
Health Exchange Alert Weekly Report - 03/02/2022
HEA Volume: 
Vol. 10, No. 9
Author: 


FTC Solicits Public Comment On PBM Impact On Drug Affordability

The Federal Trade Commission is requesting public input on how a wide range of common practices used by large, vertically integrated pharmacy benefit managers are impacting drug affordability. The RFI comes just days after FTC voted against launching an investigation to study the impact of PBM practices on drug prices and pharmacies . That investigation, which would have allowed FTC to subpoena information from companies, could have been much more aggressive than the new request for information. Key concerns the...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 02/28/2022
IDP Volume: 
Vol. 5, No. 9
Author: 


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.